PING AN HEALTHCARE AND TECHNOLOGY COMPANY LIMITED Financials Ping An Healthcare and Technology Company Limited BOERSE MUENCHEN
Equities
1XZ
KYG711391022
Healthcare Facilities & Services
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 EUR | -0.95% |
|
+6.52% | -30.00% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 54,224 | 90,769 | 26,143 | 21,047 | 18,060 | 12,429 | - | - |
| Enterprise Value (EV) 1 | 48,779 | 80,952 | 23,078 | 17,346 | 16,194 | 10,034 | 9,795 | 9,346 |
| P/E ratio | -69.6 x | -86 x | -16.6 x | -33.6 x | -53.8 x | -62.4 x | -32,673 x | 203 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 10.7 x | 13.2 x | 3.56 x | 3.42 x | 3.86 x | 2.32 x | 2.02 x | 1.87 x |
| EV / Revenue | 9.63 x | 11.8 x | 3.15 x | 2.82 x | 3.46 x | 1.87 x | 1.59 x | 1.4 x |
| EV / EBITDA | -59.9 x | -108 x | -16.1 x | -31.9 x | -36 x | -29.9 x | -76.4 x | 164 x |
| EV / FCF | -76.5 x | -68.9 x | -15.5 x | -20.5 x | -49.7 x | -38.3 x | 350 x | 44 x |
| FCF Yield | -1.31% | -1.45% | -6.47% | -4.87% | -2.01% | -2.61% | 0.29% | 2.27% |
| Price to Book | 5.62 x | 5.73 x | 1.88 x | 1.56 x | 1.36 x | 0.95 x | 0.95 x | 0.93 x |
| Nbr of stocks (in thousands) | 1,067,294 | 1,147,294 | 1,131,742 | 1,118,813 | 1,118,813 | 1,118,813 | - | - |
| Reference price 2 | 50.81 | 79.12 | 23.10 | 18.81 | 16.14 | 11.11 | 11.11 | 11.11 |
| Announcement Date | 11/02/20 | 02/02/21 | 15/03/22 | 13/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,065 | 6,866 | 7,334 | 6,160 | 4,674 | 5,362 | 6,159 | 6,654 |
| EBITDA 1 | -813.7 | -749.4 | -1,437 | -544 | -449.4 | -335.4 | -128.2 | 57.03 |
| EBIT 1 | -959.4 | -919.1 | -1,643 | -697.8 | -575.3 | -382.2 | -188 | 48.27 |
| Operating Margin | -18.94% | -13.39% | -22.41% | -11.33% | -12.31% | -7.13% | -3.05% | 0.73% |
| Earnings before Tax (EBT) 1 | -734.1 | -941.3 | -1,524 | -607.7 | -331.9 | -225.8 | -19.95 | 169.3 |
| Net income 1 | -733.9 | -948.5 | -1,538 | -607.6 | -322.6 | -195.4 | 5.552 | 92.86 |
| Net margin | -14.49% | -13.81% | -20.97% | -9.86% | -6.9% | -3.64% | 0.09% | 1.4% |
| EPS 2 | -0.7300 | -0.9200 | -1.390 | -0.5600 | -0.3000 | -0.1781 | -0.000340 | 0.0547 |
| Free Cash Flow 1 | -637.2 | -1,175 | -1,492 | -845.1 | -325.8 | -261.7 | 28 | 212.3 |
| FCF margin | -12.58% | -17.12% | -20.35% | -13.72% | -6.97% | -4.88% | 0.45% | 3.19% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 372.29% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 504.32% | 228.67% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 11/02/20 | 02/02/21 | 15/03/22 | 13/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,747 | 4,119 | 3,818 | 3,516 | 2,828 | 3,332 | 2,222 | 2,451 | 2,111 | 2,249 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | -988.4 | -706.2 | -461.8 | -236.1 | -357.1 | -218.2 | - | - |
| Operating Margin | - | - | -25.89% | -20.09% | -16.33% | -7.09% | -16.07% | -8.9% | - | - |
| Earnings before Tax (EBT) | - | - | - | -652.9 | - | - | -244.3 | -87.63 | - | - |
| Net income | - | - | - | - | - | - | -244.6 | -77.98 | - | - |
| Net margin | - | - | - | - | - | - | -11.01% | -3.18% | - | - |
| EPS | - | - | -0.8000 | -0.5900 | -0.3900 | -0.1700 | -0.2300 | -0.0700 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 24/08/21 | 02/02/21 | 24/08/21 | 15/03/22 | 18/08/22 | 13/03/23 | 24/08/23 | 19/03/24 | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 5,445 | 9,816 | 3,065 | 3,701 | 1,867 | 2,394 | 2,634 | 3,083 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -637 | -1,175 | -1,492 | -845 | -326 | -262 | 28 | 212 |
| ROE (net income / shareholders' equity) | -7.39% | -7.44% | -10.3% | -4.41% | -2.41% | -1.49% | -0.04% | 0.72% |
| ROA (Net income/ Total Assets) | -5.93% | -6.13% | -8.44% | -3.47% | -0.79% | -1.52% | -0.29% | 0.15% |
| Assets 1 | 12,376 | 15,471 | 18,222 | 17,511 | 40,886 | 12,871 | -1,937 | 61,905 |
| Book Value Per Share 2 | 9.040 | 13.80 | 12.30 | 12.00 | 11.90 | 11.70 | 11.70 | 12.00 |
| Cash Flow per Share 2 | -0.5000 | -1.070 | -1.270 | -0.7500 | -0.2600 | 0.0900 | 0.2500 | 0.4800 |
| Capex 1 | 133 | 73.2 | 89.2 | 34.4 | 43 | 56.9 | 61.2 | 66.3 |
| Capex / Sales | 2.63% | 1.07% | 1.22% | 0.56% | 0.92% | 1.06% | 0.99% | 1% |
| Announcement Date | 11/02/20 | 02/02/21 | 15/03/22 | 13/03/23 | 19/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
11.11
CNY
Average target price
15.77
CNY
Spread / Average Target
+41.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.67% | 88.39B | |
| -23.73% | 75.6B | |
| +3.24% | 26.87B | |
| -12.06% | 16.85B | |
| -0.02% | 15.31B | |
| +75.93% | 13.53B | |
| +82.63% | 13.48B | |
| -24.56% | 13.01B | |
| +23.23% | 12.57B |
- Stock Market
- Equities
- 1833 Stock
- 1XZ Stock
- Financials Ping An Healthcare and Technology Company Limited